Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Tan Chan, M.D.

Co-Author

This page shows the publications co-authored by Andrew Chan and Manish Gala.
Connection Strength

2.314
  1. TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer. Cancer Prev Res (Phila). 2015 Jul; 8(7):614-9.
    View in: PubMed
    Score: 0.615
  2. Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res. 2015 Apr 01; 21(7):1543-8.
    View in: PubMed
    Score: 0.600
  3. Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial. Cancer Prev Res (Phila). 2020 10; 13(10):877-888.
    View in: PubMed
    Score: 0.222
  4. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Trials. 2017 02 01; 18(1):50.
    View in: PubMed
    Score: 0.174
  5. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 2021 07; 70(7):1325-1334.
    View in: PubMed
    Score: 0.058
  6. Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2719-2728.
    View in: PubMed
    Score: 0.056
  7. Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. Int J Epidemiol. 2020 02 01; 49(1):259-269.
    View in: PubMed
    Score: 0.054
  8. Corrigendum to: Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. Int J Epidemiol. 2020 02 01; 49(1):352.
    View in: PubMed
    Score: 0.054
  9. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.051
  10. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst. 2019 02 01; 111(2):146-157.
    View in: PubMed
    Score: 0.050
  11. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 01; 51(1):76-87.
    View in: PubMed
    Score: 0.049
  12. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol. 2018 09 25; 19(1):142.
    View in: PubMed
    Score: 0.049
  13. Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer. 2016 Dec 15; 139(12):2655-2670.
    View in: PubMed
    Score: 0.042
  14. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.042
  15. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology. 2016 Aug; 151(2):351-363.e28.
    View in: PubMed
    Score: 0.041
  16. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis. 2016 Jan; 37(1):87-95.
    View in: PubMed
    Score: 0.040
  17. Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun. 2015 Oct 26; 6:8739.
    View in: PubMed
    Score: 0.040
  18. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun. 2015 Jul 07; 6:7138.
    View in: PubMed
    Score: 0.039
  19. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis. 2015 Sep; 36(9):999-1007.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.